secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001193125-25-192794
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta exchanges $700M convertible notes for $602M new 4.875% notes due 2030 plus stock and cash
--------------------------------------------------------------------------------

- Exchanged $700M of 1.25% Convertible Notes due 2027 for $602M of 4.875% Convertible Notes due 2030, 5.85M common shares, and ~$123.3M cash.
- New notes mature Sept 1, 2030; initial conversion price ~$60.00/share (191.5% premium over $20.58 close on Aug 20, 2025).
- Concurrent private placement of 1,106,806 shares to J. Wood Capital at $18.07 per share.
- New notes bear 4.875% cash interest, payable semiannually; callable from Sept 6, 2028 if stock price ≥ 130% of conversion price.
- Holders may convert upon stock price triggers (≥130% of conversion price for 20 of 30 days) or specified corporate events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312525192794/0001193125-25-192794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312525192794/d945054d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-192794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer